Phosphorylase Kinase b-Subunit Fragment (420-436)

Phosphorylase Kinase b-Subunit Fragment (420-436)

Phosphorylase Kinase b-Subunit Fragment (420-436)

Phosphorylase Kinase b-Subunit Fragment (420-436)

Phosphorylase Kinase b-Subunit Fragment (420-436)

Phosphorylase Kinase b-Subunit Fragment (420-436) is a synthetic 17-amino acid peptide corresponding to residues 420-436 of the beta subunit of Phosphorylase Kinase (PhK). This specific sequence represents a functionally important region within the regulatory domain of the beta subunit, which is critical for the calcium/calmodulin-dependent activation of the PhK holoenzyme. Supplied as a high-purity lyophilized powder, this peptide serves as a specialized research tool for studying the structure, function, and regulation of this key glycogenolytic enzyme complex.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Phosphorylase Kinase b-Subunit Fragment (420-436)
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C79H130N31O25S
Molecular Weight
1946.2g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, 0.1% TFA, or dilute aqueous buffers (up to 10 mg/mL)

Endotoxin≤1.0 EU/mg
Biological Activity
 Serves as a specific substrate for phosphorylase kinase; used to measure kinase activity in enzymatic assays and validate antibody recognition
Storage Conditions
Store at -20°C; stable for 24 months when desiccated. Avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide fragment does not possess intrinsic enzymatic activity. Instead, it functions as a molecular probe or regulator that interacts with specific components of the PhK complex or its modulators. The beta subunit of PhK acts as both a substrate for PKA (Protein Kinase A) phosphorylation and a regulatory module.


    2.PRODUCT INDICATIONS

  • Enzyme Regulation Studies: Investigating the molecular mechanism of calcium/calmodulin activation of Phosphorylase Kinase by using the peptide as a competitive inhibitor or probe in in vitroactivation assays.

  • Antibody Production: Conjugating the peptide to a carrier protein to generate polyclonal or monoclonal antibodies specific to this region of the PhK beta subunit for use in Western blotting, immunohistochemistry, or immunoprecipitation.

  • Phosphorylation Site Analysis: Studying the kinetics and consequences of phosphorylation within this specific region by PKA or other kinases, using the peptide as a simplified model substrate.

  • Protein-Protein Interaction Mapping: Utilizing the peptide in pull-down assays, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC) to map its interaction with calmodulin or other regulatory proteins.

  • Structure-Function Analysis: Employing the peptide in studies aimed at understanding how this specific segment contributes to the overall regulatory function of the PhK beta subunit.

  • Metabolic Disorder Research: Serving as a tool to dissect PhK dysfunction in glycogen storage diseases (like some forms of PhK deficiency) at a molecular level.

     

    3.CLINICAL EFFICACY OF PRODUCT

  • Research Tool Efficacy: Its "efficacy" lies in its utility as a precise molecular tool to dissect the complex regulation of Phosphorylase Kinase, a central enzyme in energy metabolism. It enables high-resolution studies not possible with the full, multi-subunit holoenzyme.

  • Disease Research Context: Phosphorylase Kinase deficiencies are known causes of glycogen storage diseases (e.g., some forms of liver and muscle glycogenosis). Research using such specific fragments helps elucidate the molecular defects (e.g., impaired calmodulin binding, altered phosphorylation) underlying these genetic disorders.

  • Therapeutic Target Insight: While PhK itself is not a direct drug target, understanding its regulation is crucial for broader metabolic research. Insights into calcium/calmodulin-mediated enzyme activation can inform research into other signaling pathways relevant to metabolic syndrome, diabetes, and cardiac hypertrophy.

  • Clinical Translation Gap: The peptide itself is not a drug candidate. Its value is in generating fundamental knowledge about a critical metabolic enzyme, which may indirectly inform the understanding of related pathologies or signaling networks.


  • 4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.